ASIA PACIFIC INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

ASIA PACIFIC INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

There are many biological and other causes for infertility, including some that medical intervention can treat. The most common cause of female infertility is ovulatory problems which generally manifest on account of sparse or absent menstrual periods. The infertility testing and treatment market in the Asia Pacific is anticipated to grow with a CAGR of about 7.06% during the forecast period 2019-2027. The market has been valued at $XX million in the year 2018 and is depicted to generate a revenue of about $XX million by 2027.

ASIA PACIFIC INFERTILITY TESTING AND TREATMENT MARKET FORECAST 2019-2027

Request free sample

There are many biological and other causes for infertility, including some that medical intervention can treat. The most common cause of female infertility is ovulatory problems which generally manifest on account of sparse or absent menstrual periods.

The infertility testing and treatment market in the Asia Pacific is anticipated to grow with a CAGR of about 7.06% during the forecast period 2019-2027. The market has been valued at $XX million in the year 2018 and is depicted to generate a revenue of about $XX million by 2027.

Growing male infertility, high middle-class income, increasing number of couples opting for surrogacy and booming medical tourism are some of the key trends witnessed by the Asia-Pacific infertility testing and treatment market. Asia-Pacific offers a mixture of markets with a classic marketing situation of low awareness and low demand. Increasing awareness levels is expected to play a significant role in boosting market revenues of the infertility market.

Rising medical tourism in South Korea due to the low cost of technology in the region acts as a major driver for this market. The other key markets in the Asia-Pacific region considered for the market analysis are India, Japan, South Korea, China and Rest of Asia Pacific. The South Korean market is predicted to grow with the highest CAGR over the projected years.

Due to a low birth rate, governments of countries like South Korea, Japan, Singapore and Taiwan offering to subsidize the cost of infertility treatments. The Japan infertility testing and treatment market accounted for the highest revenue share in 2018 for the Asia-Pacific region. According to Japan’s Association of Obstetricians and Gynecologists, one out of 27 babies born in Japan in 2012 was through test-tube fertilization/IVF.

Few of the established companies in this region include Andrology Solutions, Origio, The Cooper Companies, Inc., Vitrolife AB, Ferring Pharmaceuticals, Irvine Scientific, Merck, Endo Pharmaceuticals, Halotech DNA, Thermo Fisher Scientific Inc., Quest Diagnostic, Genea, Progyny, Esco Micro PTE. Ltd., and Ovascience.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • ASIA PACIFIC IS THE FASTEST GROWING REGION IN THE INFERTILITY MARKET
      • IVF DOMINATES THE FEMALE TREATMENT MARKET
      • OXIDATIVE STRESS ANALYSIS IS THE FASTEST GROWING MALE INFERTILITY TESTING MARKET
  1. MARKET OVERVIEW
    • MARKET DEFINITION
    • MARKET DRIVERS AND IMPACT
      • RISE IN INFERTILITY AND TREATMENT AWARENESS
      • MEDICAL TOURISM FOR FERTILITY TREATMENTS
      • SURROGACY LAWS ARE GETTING MORE DEFINED
      • HEALTHCARE ADVANCES HAVE FINETUNED FERTILITY TREATMENT
      • INCREASING EFFECTIVENESS OF TREATMENTS
      • HEALTHIER DONOR EGGS
      • INTRODUCTION OF NEW TESTING DEVICES
    • MARKET RESTRAINTS AND IMPACT
      • TREATMENT PROCEDURE OUT OF REACH TO MANY DUE TO COSTS INVOLVED
      • COUNTRY-WISE REGULATORY ISSUES
    • MARKET OPPORTUNITIES
      • REDUCING THE COST OF TREATMENT TO MAKE IT MORE ACCESSIBLE
      • IVF ATTRACTING INVESTMENTS FROM PRIVATE EQUITY INVESTORS
      • DIY TESTING INCREASING ACCESS AND REDUCING COST
    • MARKET CHALLENGES
      • INFERTILITY CONSIDERED A SOCIAL TABOO AMONGST MEN
      • PERILS OF MULTIPLE PREGNANCIES
      • TRADITIONAL TREATMENTS USED WIDELY AS AN ALTERNATIVE FOR INFERTILITY TREATMENTS
        • DIET AND SUPPLEMENTS
        • ACUPUNCTURE
        • THERAPY
        • QIGONG
  1. INFERTILITY CAUSES
    • CAUSES OF MALE INFERTILITY
      • ABNORMALITY IN THE SPERM
      • ENVIRONMENTAL FACTORS
      • POOR HEALTH AND LIFESTYLE
    • CAUSES OF FEMALE INFERTILITY
      • OVULATION DISORDERS
      • DAMAGE TO FALLOPIAN TUBES
    • MORAL QUESTIONS
  2. MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY MALE INFERTILITY TESTING
      • DNA FRAGMENTATION
      • OXIDATIVE STRESS ANALYSIS
      • SPERM PENETRATION ASSAY
      • COMPUTER ASSISTED SEMEN ANALYSIS (CASA)
      • SPERM AGGLUTINATION
      • MICROSCOPIC EXAMINATION
      • OTHERS
    • MARKET BY MALE INFERTILITY TREATMENT
      • VASOVASOSTOMY AND VASOEPIDIDYMOSTOMY (VASECTOMY REVERSAL)
      • SPERM RETRIEVAL TREATMENT
      • MICROSURGICAL SPERM ASPIRATION (MESA)
      • TESTICULAR SPERM EXTRACTION (TESE)
      • VARICOCELE REPAIRS
      • ASSISTED REPRODUCTIVE TECHNIQUES (ART)
      • INTRAUTERINE INSEMINATION (IUI)
      • IN VITRO FERTILIZATION (IVF)
      • INTRACYTOPLASMIC SPERM INJECTION (ICSI)
  1. FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY FEMALE INFERTILITY TESTING
      • OVULATION TESTING
      • HYSTEROSALPINGOGRAPHY
      • LAPAROSCOPY
      • TRANSVAGINAL ULTRASOUND
      • OVARIAN RESERVE TESTING
      • HORMONAL LEVEL TESTING
      • OTHERS (GENETIC TESTING)
    • MARKET BY FEMALE INFERTILITY TREATMENT
      • IN VITRO FERTILIZATION
      • INTRAUTERINE INSEMINATION (IUI)
      • DRUG AND HORMONE THERAPIES
  1. ASIA PACIFIC INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS
  2. KEY ANALYTICS
    • PORTER’S 5 FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
      • RAW MATERIAL PROCUREMENT
      • MANUFACTURING
      • SUPPLY LOGISTICS
      • DISTRIBUTION CHANNELS
      • END-USERS
    • KEY BUYING CRITERIA
      • TREATMENT OPTIONS
      • QUALITY OF MEDICAL PROCEDURES
      • PRICE OF TREATMENTS
      • SHIFT TOWARDS MEDICAL TOURISM
      • REIMBURSEMENT
    • REGULATORY FRAMEWORK
    • VENDOR LANDSCAPE
    • OPPORTUNITY MATRIX
  3. ASIA PACIFIC INFERTILITY TESTING AND TREATMENT MARKET COUNTRY ANALYSIS 2019-2027 ($ MILLION)
    • CHINA
    • INDIA
    • JAPAN
    • SOUTH KOREA
    • REST OF ASIA-PACIFIC
  4. COMPANY PROFILES
    • ANDROLOGY SOLUTIONS
    • ENDO PHARMACEUTICALS
    • PROGYNY
    • FERRING PHARMACEUTICALS
    • GENEA
    • HALOTECH DNA
    • IRVINE SCIENTIFIC
    • MERCK
    • ORIGIO
    • OVASCIENCE
    • VITROLIFE AB
    • THERMO FISHER SCIENTIFIC INC.
    • THE COOPER COMPANIES, INC.
    • QUEST DIAGNOSTIC
    • ESCO MICRO PTE. LTD.

 

LIST OF TABLES

TABLE 1 ASIA PACIFIC INFERTILITY TESTING AND TREATMENT MARKET BY GENDER 2019-2027 ($ MILLION)

TABLE 2 AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS

TABLE 3 ASIA PACIFIC MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 4 ASIA PACIFIC MALE INFERTILITY TESTING MARKET 2019-2027 ($ MILLION)

TABLE 5 PROS AND CONS OF DNA SHARING METHODS

TABLE 6 ASIA PACIFIC FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 7 ASIA PACIFIC FEMALE INFERTILITY TESTING MARKET 2019-2027 ($ MILLION)

TABLE 8 ASIA PACIFIC FEMALE INFERTILITY TREATMENT MARKET 2019-2027 ($ MILLION)

TABLE 9 AVERAGE COST OF SOME INFERTILITY TREATMENTS

TABLE 10 SOME COMMON DRUG THERAPIES

TABLE 11 ASIA PACIFIC INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)

TABLE 12 ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET BY COUNTRY 2019-2027 ($ MILLION)

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 2 MAJOR FERTILITY TREATMENT DESTINATION RANKING

FIGURE 3 CLINICAL ALGORITHM FOR THE EVALUATION OF INFERTILE WOMAN

FIGURE 4 RATE OF MULTIPLE DELIVERIES

FIGURE 5 CAUSES OF INFERTILITY

FIGURE 6 CAUSES OF INFERTILITY BASED ON GENDER

FIGURE 7 CAUSES OF SPERM DNA FRAGMENTATION

FIGURE 8 GROWTH IN IVF CLINICS IN ASIA

FIGURE 9 CHINA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 10 INDIA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

FIGURE 11 JAPAN INFERTILITY TESTING AND TREATMENT MARKET 2019-2027(MILLION)

FIGURE 12 SOUTH KOREA INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 (MILLION)

FIGURE 13   MEDICAL TOURISM IN SOUTH KOREA ($ MILLION)

FIGURE 14 REST OF ASIA-PACIFIC INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)

 

  1. ASIA PACIFIC INFERTILITY TESTING AND TREATMENT MARKET COUNTRY ANALYSIS 2019-2027 ($ MILLION)
    • CHINA
    • INDIA
    • JAPAN
    • SOUTH KOREA
    • REST OF ASIA-PACIFIC
  2. MALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY MALE INFERTILITY TESTING
      • DNA FRAGMENTATION
      • OXIDATIVE STRESS ANALYSIS
      • SPERM PENETRATION ASSAY
      • COMPUTER ASSISTED SEMEN ANALYSIS (CASA)
      • SPERM AGGLUTINATION
      • MICROSCOPIC EXAMINATION
      • OTHERS
    • MARKET BY MALE INFERTILITY TREATMENT
      • VASOVASOSTOMY AND VASOEPIDIDYMOSTOMY (VASECTOMY REVERSAL)
      • SPERM RETRIEVAL TREATMENT
      • MICROSURGICAL SPERM ASPIRATION (MESA)
      • TESTICULAR SPERM EXTRACTION (TESE)
      • VARICOCELE REPAIRS
      • ASSISTED REPRODUCTIVE TECHNIQUES (ART)
      • INTRAUTERINE INSEMINATION (IUI)
      • IN VITRO FERTILIZATION (IVF)
      • INTRACYTOPLASMIC SPERM INJECTION (ICSI)
  1. FEMALE INFERTILITY TESTING AND TREATMENT MARKET 2019-2027 ($ MILLION)
    • MARKET BY FEMALE INFERTILITY TESTING
      • OVULATION TESTING
      • HYSTEROSALPINGOGRAPHY
      • LAPAROSCOPY
      • TRANSVAGINAL ULTRASOUND
      • OVARIAN RESERVE TESTING
      • HORMONAL LEVEL TESTING
      • OTHERS (GENETIC TESTING)
    • MARKET BY FEMALE INFERTILITY TREATMENT
      • IN VITRO FERTILIZATION
      • INTRAUTERINE INSEMINATION (IUI)
      • DRUG AND HORMONE THERAPIES
  1. ASIA PACIFIC INFERTILITY TESTING AND TREATMENT MARKET BY END-USERS 2019-2027 ($ MILLION)
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now